amoxicillin or moxifloxacin
Phase 3Small molecule
amoxicillin or moxifloxacin is one of 4 small molecule programs targeting Infections Joint Prosthetic. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
3 competitors in Infections Joint Prosthetic
#DrugCompanyPhaseTrials
1Keflex
Eli LillyApproved
Vibramycin
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Cefadroxil
TevaApproved
amoxicillin or moxifloxacin
CCentre Hospitalier Universitaire de Nice
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for amoxicillin or moxifloxacin. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details